Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Men who are having a prostate biopsy (through either the rectum or the perineum) as part of their regular medical care because prostate cancer is suspected
- Men who are medically suitable to undergo a prostate biopsy procedure, either a standard cognitive type or a fusion type that combines imaging with the biopsy
- Men who are having their very first prostate biopsy, or who have not had a prostate biopsy in the past 3 years
- Men who have had a pre-biopsy MRI scan of the prostate showing one or more areas of concern rated PIRADS 3, 4, or 5 (a scoring system used by radiologists to describe how suspicious an area looks on MRI — confirm with trial site if unsure of your rating)
- Men whose largest area of concern on the MRI measures 2 cm or smaller
- Men whose PSA (prostate-specific antigen) blood test result is 20 ng/mL or below, and/or who have an abnormal result from a digital rectal examination (a physical check of the prostate performed by a doctor)
Who may not be able to join:
- Men whose MRI scan shows an area of concern larger than 2 cm
- Men who have had a prostate biopsy within the past 3 years
- Men who have previously been diagnosed with prostate cancer
- Men who have a medical reason that makes a prostate biopsy unsafe, such as a current fever, a urinary or genital infection, or other serious health conditions as assessed by their treating doctor
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Badar M Mian, MD, Albany Medical College
Phone: 5182623296
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Detection of clinically significant prostate cancer
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.